1/14
08:30 am
rnxt
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
Low
Report
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
1/8
08:30 am
rnxt
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
Medium
Report
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
12/30
04:14 pm
rnxt
RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
09:13 am
rnxt
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026 [Yahoo! Finance]
Low
Report
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026 [Yahoo! Finance]
12/11
08:30 am
rnxt
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026
Low
Report
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026
12/1
08:30 am
rnxt
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th
Medium
Report
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th
11/26
02:15 pm
rnxt
RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
08:06 am
rnxt
RenovoRx (NASDAQ:RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $12.00 to $12.50. They now have a "buy" rating on the stock.
Medium
Report
RenovoRx (NASDAQ:RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $12.00 to $12.50. They now have a "buy" rating on the stock.
11/19
08:30 am
rnxt
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th
Medium
Report
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th
11/12
08:37 am
rnxt
RenovoRx Inc (RNXT) Q3 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
Medium
Report
RenovoRx Inc (RNXT) Q3 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
11/6
08:30 am
rnxt
RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD
Medium
Report
RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD
11/4
04:13 pm
rnxt
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th [Yahoo! Finance]
Low
Report
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th [Yahoo! Finance]
11/4
08:30 am
rnxt
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th
Medium
Report
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th
10/27
08:30 am
rnxt
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET
Low
Report
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET
10/25
01:32 am
rnxt
Low
Report